Supplement for Reduction of Cardiovascular Disease on Trial

November 8, 2005

Supplement for Reduction of Cardiovascular Disease on Trial

Animi-3 Clinical Trial Featured in The Heartzine Magazine

PBM Pharmaceuticals Inc. announced yesterday that it is conducting a clinical trial of the active supplement Animi-3®, designed to study the related cardiovascular risk reduction.

Animi-3® is a prescription-only product that contains specially formulated and highly refined omega-3 fatty acids as well as folic acid, vitamin B6 and vitamin B12.

The six-month, double-blind, randomized, placebo-controlled study is conducted by Dr. Ernst J. Schaefer, M.D., of Cardiovascular Research Associates, in Boston, MA and Professor of Medicine at Tufts University School of Medicine. It started in September 2005 and has 75 participants, aged 55-80, with no prior history of dementia.

Since studies published in peer-reviewed journals have reported that patients with heart disease, diabetes, rheumatoid arthritis and depression may be deficient in omega-3 fatty acids, folic acid, and vitamins B6 and B12, this supplement will be beneficial for these patients.

Apart from studying the decreases in triglycerides, homocysteine, and small dense LDL, and the increases in large HDL, scientists will investigate the effects of Animi-3® on C-Reactive protein as well as the measures of cognitive functions, including memory and executive function.

“The ingredients in Animi-3 benefit cardiovascular disease, cognition, and rheumatoid arthritis”, says Dr. Barbara Levine, of Weill Medical College of Cornell University, involved with the launch of the product. Dr. Levine is an expert on nutritional interactions between genetics and the prevention of cardiovascular disease, diabetes, and cancer. “Scientists and clinicians at Cornell University are actively prescribing the product and following up with patients on Animi-3”, she adds.

The Heartzine Magazine covers everything relating to the heart, from anatomy, through physiology and covering pathology. By combining the basics, detailed information, as well as new advances, Heartzine represents an all-in-one guide to the heart and the circulatory system.